1. Home
  2. FLC vs RGC Comparison

FLC vs RGC Comparison

Compare FLC & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLC
  • RGC
  • Stock Information
  • Founded
  • FLC 2003
  • RGC 2014
  • Country
  • FLC United States
  • RGC Hong Kong
  • Employees
  • FLC N/A
  • RGC N/A
  • Industry
  • FLC Trusts Except Educational Religious and Charitable
  • RGC Medicinal Chemicals and Botanical Products
  • Sector
  • FLC Finance
  • RGC Health Care
  • Exchange
  • FLC Nasdaq
  • RGC Nasdaq
  • Market Cap
  • FLC 168.0M
  • RGC 171.1M
  • IPO Year
  • FLC N/A
  • RGC 2021
  • Fundamental
  • Price
  • FLC $17.11
  • RGC $5.66
  • Analyst Decision
  • FLC
  • RGC
  • Analyst Count
  • FLC 0
  • RGC 0
  • Target Price
  • FLC N/A
  • RGC N/A
  • AVG Volume (30 Days)
  • FLC 37.8K
  • RGC 28.0K
  • Earning Date
  • FLC 01-01-0001
  • RGC 10-25-2024
  • Dividend Yield
  • FLC 6.64%
  • RGC N/A
  • EPS Growth
  • FLC N/A
  • RGC N/A
  • EPS
  • FLC N/A
  • RGC N/A
  • Revenue
  • FLC N/A
  • RGC N/A
  • Revenue This Year
  • FLC N/A
  • RGC N/A
  • Revenue Next Year
  • FLC N/A
  • RGC N/A
  • P/E Ratio
  • FLC N/A
  • RGC N/A
  • Revenue Growth
  • FLC N/A
  • RGC N/A
  • 52 Week Low
  • FLC $12.62
  • RGC $3.03
  • 52 Week High
  • FLC $15.45
  • RGC $32.44
  • Technical
  • Relative Strength Index (RSI)
  • FLC 77.26
  • RGC 40.22
  • Support Level
  • FLC $16.79
  • RGC $5.05
  • Resistance Level
  • FLC $16.96
  • RGC $6.57
  • Average True Range (ATR)
  • FLC 0.13
  • RGC 0.74
  • MACD
  • FLC 0.01
  • RGC -0.25
  • Stochastic Oscillator
  • FLC 96.92
  • RGC 16.85

About FLC Flaherty & Crumrine Total Return Fund Inc

Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.

About RGC Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.

Share on Social Networks: